LivaNova trades as part of the medical devices industry and is in the healthcare sector. The company CEO is Damien McDonald. LivaNova is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics, a medical device company with core expertise in neuromodulation.
Previous Intraday Trading Performance:
The LIVN stock showed a previous change of 2.30% with an open at 72.55 and a close of 73.41. It reached an intraday high of 73.81 and a low of 71.77.
Business Wire: LivaNova to Present at the Jefferies Healthcare Conference
Liquidity:
The stock has a market cap of $3.5b with 48.3m shares outstanding, of which the float is 46.9m shares. Trading volume reached 389,020 shares compared to its average volume of 572,959 shares. Based on the current average volume and close price, the trading liquidity is good.
Historical Trading Performance:
Over the last five trading days, LivaNova shares returned 2.13% and in the past 30 trading days it returned 8.32%. Over three months, it changed -22.14%. In one year it has changed -23.45% and within that year its 52-week high was 131.54 and its 52-week low was 64.80. LIVN stock is 13.29% above its 52 Week Low.
Our calculations show a 200 day moving average of 98.40 and a 50 day moving average of 75.51. Currently LIVN stock is trading -25.40% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.
Business Wire: LivaNova to Present at the Jefferies Healthcare Conference
Earnings:
The last annual fiscal EPS for the company was reported at -3.91 that ended on 31st of December 2018. Based on 3 analyst estimates, the consensus EPS for the next quarter is 0.53. The TTM EPS is 3.04, which comes to a TTM PE of 24.15.
Below was the last reported quarterly diluted earnings per share:
| 1st | Qtr of 2019 | (Reported on 05/01/2019): | -0.31 |
|---|---|---|---|
| 4th | Qtr of 2018 | (Reported on 02/27/2019): | -4.34 |
| 3rd | Qtr of 2018 | (Reported on 10/31/2018): | -0.15 |
| 2nd | Qtr of 2018 | (Reported on 08/01/2018): | 0.31 |
| 1st | Qtr of 2018 | (Reported on 05/02/2018): | 0.27 |
Base on our calculations, the intrinsic value per share is 88.95, which means it is possibly undervalued and has a margin of safety of 17.47%.
Indicators to Watch:
The current calculated beta is 0.38.
SeekingAlpha: Short-Sellers’ Favorites: Highest Short Interest Stocks May 2019
Fundamental Indicators:
Based on last reported financials, the company’s return on equity is -13.84%, return on assets is -8.59%, profit margin is -19.70%, price-to-sales is 3.13 and price-to-book is 2.33.
Company Scores:
All scores are out of six:
1 :Valuation Score
0 :Past Performance Score
3 :Financial Strength Score
3 :Future Growth Score
0 :Dividend Score
1 :Overall Score
